Premium
Response to “CYP2C9 Polymorphism is Not a Major Determinant of Bosentan Exposure in Healthy Volunteers”
Author(s) -
Markova S M,
Schwartz J B,
Kroetz D L
Publication year - 2014
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2013.239
Subject(s) - library science , medicine , gerontology , computer science